Search Results 2151-2160 of 20178 for Receptor

  1. A Study of the Safety and Effectiveness of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration - Mayo Clinic

    Treatment with systemic anti-VEGF medication (e.g., bevacizumab, ziv-aflibercept) or VEGF-receptor inhibitor (e.g., sunitinib, sorafenib, pazopanib) within ...

  2. A Study To Investigate The Safety And Preliminary Efficacy Of ALLO-329, An Allogeneic CAR T-cell Therapy, In Adults With Autoimmune Disease - Mayo Clinic

    The purpose of this trial is to evaluate the safety and tolerability of ALLO-329, an allogeneic anti-CD19, anti-CD70 dual chimeric antigen receptor (CAR) T ...

  3. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  4. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  5. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  6. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  7. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  8. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  9. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  10. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...